Stay updated with breaking news from Johnc Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2.10.2023 - The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax's adjuvant is critical to reducing over half a million malaria-related deaths annually.
The R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many as hundreds of millions of doses to be supplied to countries...
NVX-CoV2601 vaccine adjuvanted 2023-2024 formula granted EUA for the prevention of COVID-19 in those 12 years of age and older.
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the...
Today the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted in favor of a universal recommendation for the use of 2023-2024 COVID-19...